XML 34 R28.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Segment Information (Tables) | 6 Months Ended
--- | ---
Dec. 31, 2013
Segment Reporting [Abstract] |
Revenue by Reportable Segment | The following tables present revenue for each reportable segment and reconciling items necessary to agree to amounts reported in the condensed consolidated statements of earnings:
| Three Months Ended December 31
(in millions) | 2013 |  | 2012
Pharmaceutical (1) | $ | 19,443 |  |  | $ | 22,747 |
Medical | 2,799 |  |  | 2,487 |
Total segment revenue | 22,242 |  |  | 25,234 |
Corporate (2) | (2 | ) |  | (2 | )
Total revenue | $ | 22,240 |  |  | $ | 25,232 |
| Six Months Ended December 31
(in millions) | 2013 |  | 2012
Pharmaceutical (1) | $ | 41,256 |  |  | $ | 46,244 |
Medical | 5,511 |  |  | 4,879 |
Total segment revenue | 46,767 |  |  | 51,123 |
Corporate (2) | (4 | ) |  | (2 | )
Total revenue | $ | 46,763 |  |  | $ | 51,121 |
(1) | The decrease in Pharmaceutical segment revenue is primarily due to the expiration of our pharmaceutical distribution contract with Walgreens.
(2) | Corporate revenue consists of the elimination of inter-segment revenue.
Segment Profit by Reportable Segment | The following tables present segment profit by reportable segment and reconciling items necessary to agree to amounts reported in the condensed consolidated statements of earnings:
| Three Months Ended December 31
(in millions) | 2013 |  | 2012
Pharmaceutical | $ | 482 |  |  | $ | 441 |
Medical | 131 |  |  | 94 |
Total segment profit | 613 |  |  | 535 |
Corporate | (94 | ) |  | (29 | )
Total operating earnings | $ | 519 |  |  | $ | 506 |
| Six Months Ended December 31
(in millions) | 2013 |  | 2012
Pharmaceutical | $ | 916 |  |  | $ | 841 |
Medical | 238 |  |  | 168 |
Total segment profit | 1,154 |  |  | 1,009 |
Corporate | (164 | ) |  | (46 | )
Total operating earnings | $ | 990 |  |  | $ | 963 |
Assets by Reportable Segments | The following table presents total assets for each reportable segment and reconciling items necessary to agree to amounts reported in the condensed consolidated balance sheets at the dates indicated below:
(in millions) | December 31, 2013 |  | June 30, 2013
Pharmaceutical (1) | $ | 14,985 |  |  | $ | 16,258 |
Medical | 6,558 |  |  | 6,521 |
Corporate | 3,466 |  |  | 3,040 |
Total assets | $ | 25,009 |  |  | $ | 25,819 |
(1) | The decrease in Pharmaceutical segment assets is primarily due to the expiration of our pharmaceutical distribution contract with Walgreens.

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total profit or loss from reportable segments, to the entity's consolidated income before income taxes, extraordinary items, and discontinued operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration